| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.009 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |